Andrea I. McClatchey
Massachusetts General Hospital Center for Cancer Research and Harvard Medical School Department of Pathology
Charlestown
MA, USA. Electronic address:
Name/email consistency: high
- Contact inhibition (of proliferation) redux. McClatchey, A.I., Yap, A.S. Curr. Opin. Cell Biol. (2012)
- Neurofibromatosis. McClatchey, A.I. Annu. Rev. Pathol (2007)
- Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin. McClatchey, A.I., Giovannini, M. Genes Dev. (2005)
- NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Lallemand, D., Curto, M., Saotome, I., Giovannini, M., McClatchey, A.I. Genes Dev. (2003)
- Merlin and ERM proteins: unappreciated roles in cancer development?. McClatchey, A.I. Nat. Rev. Cancer (2003)
- Mouse models of neurofibromatosis. McClatchey, A.I., Cichowski, K. Biochim. Biophys. Acta (2001)
- Neurofibromatosis type II: mouse models reveal broad roles in tumorigenesis and metastasis. McClatchey, A.I. Mol. Med. Today (2000)
- Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. McClatchey, A.I., Saotome, I., Mercer, K., Crowley, D., Gusella, J.F., Bronson, R.T., Jacks, T. Genes Dev. (1998)
- Tumor suppressor mutations in mice: the next generation. McClatchey, A.I., Jacks, T. Curr. Opin. Genet. Dev. (1998)